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Vimentin and heat shock protein expression are induced in
the kidney by angiotensin and by nitric oxide inhibition.
Background. Angiotensin II (Ang II) infusion and nitric ox-
ide synthesis (NOS) inhibition with N-nitro-l-arginine-methyl-
ester (l-NAME) are experimental models of hypertension as-
sociated with renal inflammation and oxidative stress. To gain
insight into the nature of the tubulointerstitial injury induced in
these models, we studied lectin-binding specificities, vimentin
expression, and heat shock protein (HSP) 60 and 70 in these
experimental models.
Methods. Sprague-Dawley rats received Ang II infusion
(435 ng/kg/min) for 2 weeks by subcutaneous minipumps (Ang
II group, N  5) or l-NAME in the drinking water (70 mg/
100 mL) for 3 weeks (l-NAME group N 7). The control group
consisted of 10 rats. Systolic blood pressure (tail-cuff plethys-
mography), serum creatinine, and proteinuria were determined
weekly. At the end of the treatment period, rats were sacrificed
and kidneys studied. Binding specificities of fluorescein-labeled
lectins were examined in frozen sections, and cellular infiltrates
were identified by immunohistology and expression of vimentin
and HSP 60 and 70 with immunohistochemistry and computer
image analysis.
Results. Tubulointerstitial accumulation of macrophages, lym-
phocytes, and Ang II–positive cells were present in the Ang II
group and l-NAME group. Vimentin, HSP 60, and HSP 70 were
increased 8 to 20 times in the cortex of the rats of the Ang II
group and the l-NAME groups. Neoexpression of vimentin and
HSPs was found primarily in proximal tubular cells.
Conclusion. Ang II infusion and NOS inhibition induce tu-
bular injury with epithelial cell transdifferentiation and expres-
sion of stress proteins. The role of these changes in the accumu-
lation and activation of the interstitial inflammatory infiltrate
merits further investigation.
The administration of angiotensin II (Ang II) by sub-
cutaneous minipumps and the inhibition of nitric oxide
(NOS) synthesis by ingestion of N-nitro-l-arginine
methyl-ester (l-NAME) are experimental protocols that
induce well-known models of arterial hypertension in
rats [1, 2, 3]. This hypertension is reversible. Shortly after
these treatments are stopped the blood pressure returns
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to normal and remains within normal limits if the dietary
content of sodium is restricted. However, the administra-
tion of a high-salt diet following these experimental ma-
nipulations results in a progressive rise of blood pressure.
The pathogenesis of the post-Ang II and post-l-NAME
salt-sensitive hypertension has been studied by our group.
A key feature appears to be the infiltration of lympho-
cytes and macrophages into the renal interstitium that
generates both Ang II and oxidants [4, 5]. Preventing the
infiltration by administering immunosuppressive therapy
with mycophenolate mofetil (MMF) will prevent or atten-
uate the salt-driven hypertension [4, 5]. The importance
of the interstitial infiltrate in the genesis of a hyperten-
sion induced by a high-salt diet has also been corrobo-
rated in other experimental models, such as protein over-
load proteinuria [6], and in genetically hypertensive rats
[7–9]. The mechanism appears to involve persistent renal
vasoconstriction [10], which may be mediated by the
Ang II expressed by the inflammatory cells as a conse-
quence of oxidant-mediated inactivation of nitric oxide
(NO) and endothelial dysfunction [11–13].
Modifications of normal structural components, phe-
notypic changes, exposure of neoantigens, and tubular in-
jury and regeneration are likely to occur during the pe-
riod of Ang II infusion and NOS synthesis inhibition.
These events are potentially important because they
could be at the root of the reactivity that results in the
infiltration of lymphocytes and monocytes in tubulo-
interstitial areas of the kidney. Therefore, we investi-
gated if changes in lectin-binding specificities, vimentin
expression, and induction of heat shock protein (HSP)
60, predominantly expressed in the cortex, and HSP 70,
predominantly expressed in the medulla [14], occur as a
result of the Ang II infusion and NOS inhibition proto-
cols that result in subsequent salt-sensitive hypertension.
METHODS
Experiments were done in male Sprague-Dawley rats
weighing 290 to 340 g obtained from the Instituto Nacio-
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nal de Investigaciones Cientı´ficas (Los Teques, Venezu-
ela). They had free access to water and received standard
rat chow with normal (0.4% NaCl) sodium content (Pro-
tinal, Valencia, Venezuela). Details of the experimental
protocols of Ang II infusion and NOS inhibition models
have been previously reported [4, 5]. Briefly, the Ang II
infusion model (Ang II group, N  5) consisted in the
administration of 435 ng/kg/min of Ang II (Sigma Chemi-
cal Co., St. Louis, MO, USA) during 2 weeks by surgi-
cally placed subcutaneous minipumps (Alza Corpora-
tion, Palo Alto, CA, USA). NOS inhibition (l-NAME
group, N  7) was achieved by the administration of
L-NAME in the drinking water (70 mg/100 mL) for 3
weeks. The control group consisted of 10 rats.
At the end of the experimental period rats were eu-
thanized under penthotal anesthesia and the kidneys
were harvested for histology and immunohistology.
Systolic blood pressure (SBP) was determined weekly
by tail-cuff plethysmography (IITC; Life Scientific In-
struments, Woodland Hills, CA, USA) in rats pre-condi-
tioned to the procedure. Serum creatinine and protein-
uria were determined weekly.
Histology and immunohistology
Light microscopy evaluation was done in 4m sections
of paraffin-embedded tissues stained with periodic acid-
Schiff reagent (PAS) and Trichrome stains using a semi-
quantitative glomerular sclerosis index [15] and tubulo-
interstitial damage score, as previously reported [4, 5].
Macrophage and lymphocyte infiltration was evalu-
ated by indirect immunofluorescence using monoclonal
antibodies (see later). Cellular counts in glomeruli were
expressed as positive cells with a given staining/glomeru-
lar cross-section (gcs), and in the tubulointerstitium as
positive cells/mm2.
Vimentin and HSP 60 and 70 were investigated by the
immunoperoxidase technique, as described previously [16]
using the appropriate mAbs (see later). Vimentin expres-
sion was used as a marker of tubulointerstitial injury and
epithelial/mesenchymal transdiffferentiation. Expression
of vimentin and HSPs was studied with computer-assisted
analysis of digitalized images acquired with a Zeiss Axio-
scope (Gottingen, Germany) fitted with a Kodak DC 120
digital megapixel camera as described before [1, 5]. Vi-
mentin and HSP image analysis was done in at least 5
separate sections studied under low power of each kidney.
Results of image analysis are expressed as the ratio of
positive areas (areas expressing a given element) over
the total area examined. Obviously damaged areas were
excluded from computer-assisted image analysis. All his-
tologic studies were done in a blinded fashion.
Antisera
Anti ED-1 (monoclonal antibody to macrophages; Har-
lan Bioproducts, Indianapolis, IN, USA) and anti-CD5
(clone MRCOX19; Biosource International, Camarillo,
CA, USA) were used to identify macrophages and lym-
phocytes. Vimentin was identified with mouse antirat vi-
mentin (clone V9; Dako Corp., Carpinteria, CA, USA).
HSP 60 was identified with polyclonal rabbit anti-HSP 60
antibody (Accurate Chemical & Scientific Corp., West-
bury, NY, USA). HSP 70 was identified with polyclonal
rabbit anti-HSP70 (Hsp72) (Stressgen Biotechnologies,
Victoria, Canada)
Secondary rat antimouse and donkey antirabbit anti-
bodies were purchased from Accurate Chemical and Sci-
entific Corporation.
Lectins
Lectin binding was studied in frozen sections and it was
graded with an arbitrary intensity scale (0 to 4)
in the various renal structures. The following fluores-
cein-labeled lectins were tested: Bandeiraea simplicifolia
(carbohydrate specificity, -d-Galactose-d-Glucose N-ace-
tyl); Glycine Max (carbohydrate specificity, -d-Galactose
N-acetyl-d-Galactose); Dolichus biflorus (carbohydrate
specificity, -d-Galactose N-acetyl); and Arachys hypogaea
(carbohydrate specificity, -d-Galactose-(1-3) d-Galactose
N-acetyl). Normal binding of the various lectins to the kid-
ney structures was examined in control biopsies and it
was found to agree with the report of Holtofer et al [17].
Statistical analysis
Comparison between groups were done by one-step
analysis of variance (ANOVA) with Tukey-Kramer
post-tests. Two-tailed P values are used throughout and
P 0.05 were considered statistically significant. Results
throughout the paper are given as mean  SD.
RESULTS
At the end of the experiment the rats receiving Ang
II or l-NAME were hypertensive. The Ang II group had
SBP of 228  SD, 20 mm Hg, and the l-NAME group
had SBP of 194  24 mm Hg. Control rats remained
normotensive (SBP  128  18).
Baseline serum creatinine (mg/dL) was 0.33  0.08 in
the Ang II group and 0.30  0.1 in the l-NAME group.
At the end of the experiment it had increased to 0.72 
0.12 (P  0.05) in the Ang II group and was unchanged
in the l-NAME group (0.4  0.1). Proteinuria remained
within normal limits during the experiment (10 mg/
24 h).
Histology and cellular infiltration
The glomerular histologic damage was minor in the
Ang II group and consisted of occasional glomeruli show-
ing focal glomerulosclerosis and mesangial expansion.
In the l-NAME group, the glomerulosclerosis index (0
to 400) [15] was 75 18. Tubulointerstitial damage score
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Table 1. Lectin-binding characteristics
GLOM BC PT DT CD TBM BB V
DOLICHUS BIFLORUS
Sham 0 0 1.10.7 1.10.7 0 0 0 0
Ang II 0.2 0 1.20.7 2.00.7 0 0 0 0
l-NAME 0 0 1.10.7 2.00.7 0 0 0 0
ARACHYS HYPOGEA
Sham 0.30.3 1.41.4 0.20.2 2.00.0 1.80.4 0.40.5 0.80.8 0.80.7
Ang II 0.00.3 1.40.9 0.70.3 1.60.5 2.00.0 0.70.4 0.40.4 1.00.0
l-NAME 0 1.60.6 0.50.3 1.80.4 1.80.4 0.60.4 0.70.8 1.00.2
GLYCINE MAX
Sham 0 0 0.80.4 1.60.5 2.80.8 0 0.40.6 0
Ang II 0 0 0 2.00.0 2.40.2 0 1.00.7 0.50.7
l-NAME 0 0 0 2.00.5 2.40.2 0 0.90.6 0
ANDEIRAEA SIMPLICIFOLIA
Sham 2.30.9 0 2.00.4 1.80.4 1.40.5 0 1.51.5 0
Ang II 1.40.5 0 0 1.60.5 2.00.0 0 2.50.6 0
l-NAME 1.80.6 0 1.51.2 1.50.8 2.11.2 0 2.00.9 0
Abbreviations are: BB, brush border; BC, Bowman’s capsule; CD, collecting duct; DT, distal tubule; GLOM, glomerular tuft; PT, proximal tubule; TBM, tubular
basement membrane; V, vessels (arterioles). Positive lectin binding graded on a scale of 0 to 4.
(0 to 5) was 2.9  0.7 in the Ang II group and 1.3  0.7
in the l-NAME group (P  NS).
Infiltration of macrophages, lymphocytes, and Ang II
positive cells in tubulointerstitial areas was present in
the experimental groups. Macrophages (ED1-positive
cells/mm2) were increased (P  0.05) in the rats from
Ang II group (44 34) and in the rats from the l-NAME
group (38  17) in relation to the values in the control
group (12  4). Lymphocyte infiltration was as follows:
control group, 8.8  4.4 CD5-positive cells/mm2; Ang II
group, 65  37 (P  0.05 vs. control); and l-NAME,
106  62 (P  0.001 vs. controls).
Ang II–positive cells were seldom seen in the rats from
the control group. In the experimental groups they were
present in the tubulointerstitial areas: Ang II group, 44
5 positive cells/mm2 and l-NAME group, 38  17.
Lectin binding
Lectin-binding characteristics were not significantly al-
tered by Ang II infusion or by NOS synthesis inhibition.
Results are shown in Table 1.
Vimentin and HSP expression
Relevant changes in the neoexpression of vimentin,
HSP 60, and HSP 70 were restricted to the tubulointersti-
tial areas. Figure 1 shows how vimentin and HSP 60 and
HSP 70 were significantly over-expressed in the Ang II
group and in the l-NAME group.
Normally, vimentin is expressed only in glomeruli, ar-
terioles, and interstitial fibroblasts (Fig. 2A), and the
proximal tubules are negative. Vimentin neoexpression
was demonstrated in the renal cortex of the Ang II group
and the l-NAME group, particularly in proximal tubules
and arterioles (Fig. 2B)
Expression of HSP 70 was increased in both the Ang
II group and in the l-NAME group in the proximal tu-
bules and collecting ducts in cortex (Fig. 2 C and D). The
variability of the image analysis results in the medullary
region was large and there were no significant differences
between the experimental and control groups. HSP 60
was over-expressed in the proximal tubules of the renal
cortex in both experimental groups.
DISCUSSION
Ang II infusion and l-NAME administration were as-
sociated with severe arterial hypertension as previously
reported by other groups [1, 2, 3] beside our own [4, 5].
The macrophage and lymphocyte interstitial infiltration
associated with these experimental models has also been
reported in previous studies [1, 2–5].
There were no changes in the lectin-binding patterns
after Ang II infusion and l-NAME administration. These
findings are similar to those reported by Eddy [18] in
overload proteinuria, in which intense tubulointerstitial
accumulation of immune cells occur but the lectin-bind-
ing specificity was unmodified.
Vimentin is a widely expressed intermediate filament
protein of the cytoskeleton. Vimentin filament segrega-
tion is controlled, at least in part, by the protein kinase
Aurora-B, which regulates vimentin phosphorylation
[19]. Over-expression of vimentin is a marker of tubulo-
interstitial injury and regeneration with epithelial-mes-
enchymal transdifferentiation [20]. Neoexpression of vi-
mentin has been used to define renal injury in a variety
of renal conditions, such as the non-clipped kidney in the
two-kidney one-clip Goldblatt hypertension [21], ureteral
obstruction [22], severe proteinuria [18, 23], aging [24],
and adriamycin nephropathy [25, 26]. Recent investiga-
tions indicate that activated macrophages secrete vimen-
tin [27]. These findings are of interest since the macro-
phage infiltration is a constant feature after angiotensin
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Fig. 1. Expression of vimentin (A ), heat shock protein (HSP)
60 (B ), and HSP 70 (C ) in the angiotensin II (Ang II) group,
N-nitro-L-arginine-methyl-ester (L-NAME) L-NAME group,
and control group. Values obtained by computer-image analysis
represent mean  SD. ***P  0.001, **P  0.01.
Fig. 2. Immunohistochemistry studies show
the normal expression of vimentin (A ) in the
glomeruli, arterial wall, and in occasional
interstitial fibroblasts. Intense neoexpression
of vimentin is observed in the proximal tu-
bules in a rat from the angiotensin II (Ang
II) group (B ). Over-expression of heat shock
protein (HSP) 70 in rats from the Ang II group
(D ) is evident in comparison with the control
group (C ).
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infusion [1] and nitric oxide synthesis inhibition [3]. Trans-
differentiation of tubular epithelial cells into fibroblasts/
myofibroblasts is a process regulated by transforming
growth factor  (TGF) through the Smad signaling path-
way, which is also known to be stimulated by Ang II
[20]. Work by Kobayashi et al [21] indicates that angio-
tensin II, interacting with interferon growth factor (IGF),
may influence tubulointerstitial cell kinetics and induce
vimentin expression. This work is particularly relevant
to our findings from investigations that have shown that
Ang II is produced by both infiltrating and tubulointersti-
tial cells as a consequence of both Ang II infusion and
l-NAME administration [4, 5]; therefore, Ang II may
participate in the epithelial mesenchymal transdifferenti-
ation characterized by vimentin neoexpression in these
experimental models. At any rate, the neoexpression of
vimentin in the proximal tubules is an unequivocal signal
of injury and regeneration in these areas.
Heat shock proteins are produced as an immediate
cellular response to environmental stresses such as heat,
oxidants, or ATP depletion [14]. HSP 60 and 70, among
others, are present in the kidney [28, 29]. HSP 60 is pre-
dominantly expressed in normal kidneys in the cortex
and outer medulla [14], its intrarenal distribution roughly
corresponding with the abundance of mitochondria [30].
Immunohistochemical studies [29–31] have shown sig-
nificant positive reactions in proximal tubular cells and
to a lesser extent in distal tubular cells. In contrast, HSP
70/72 tissue content increases toward the medulla [29, 31]
in a pattern similar to that of the intrarenal solute-con-
centration gradient. Intense immunostaining for HSP
70 is normally found in epithelial papillary cells and
collecting ducts [29].
Ang II is known to induce over-expression of HSP 70,
HSP 25, HSP 32, and heme-oxygenase 1 (HO-1) in the
rat kidney [32, 33]. Using serial sections, Ishizaka et al
[33] observed over-expression of HSP 70 in the same
proximal tubules in the cortex that over-expressed HSP
25 and HO-1. They concluded that Ang II triggered
similar mechanisms for up-regulation of HSP 70 and
HSP 25, and that their increase was dependent on Ang
II–receptor type I activation. In the present studies we
also found significant increments in the expression of
HSP 70 as a result of Ang II infusion and l-NAME
administration in proximal tubules and collecting ducts
in the renal cortex (Figs. 1 and 2 C and D). In addition,
we also found that the expression of HSP 60 was in-
creased by NOS synthesis inhibition. Positive areas were
particularly evident in the proximal tubular epithelium.
HSP plays a protective role against cell damage; there-
fore, our findings suggest that stressful signals resulting
from Ang II and NOS inhibition are originating in the
renal cortex. In this regard, it is interesting that HSP
protects cells from the toxic effect of reactive oxygen
species (ROS) [34], and oxidative stress, as determined
by the existence of superoxide-positive cells, has been
observed in cortical areas of the kidney in these experi-
mental models [4, 5].
The increased expression of HSP raises the question
of the participation of these HSPs in the development
and expansion of the inflammatory infiltrate. HSP may
directly promote leukocyte accumulation since several
studies have shown that HSP induces pro-inflammatory
cytokine production, as well as over-expression of adhe-
sion molecules E-selectin, ICAM-1, and VCAM-1 [35–38].
In addition, HSPs may promote antigen-specific immune
reactivity since they bind peptides in damaged tissue to
form HSP-peptide complexes with a strong immunogenic
potential [38–40]. In fact, recent work has emphasized
that HSPs have a role in antigen presentation [41] and
may act as activators of the innate immune system [42, 43]
CONCLUSION
We have shown that phenotypic changes characterized
by vimentin neoexpression and stress-related production
of HSP 60 and HSP 70 take place in the kidney as a re-
sult of Ang II infusion and l-NAME. The location of
these changes corresponds to the tubulointerstitial areas
where the existence of inflammation and oxidative stress
have been linked to the development of salt sensitive
hypertension [4, 5]. Further studies are needed to clarify
the relationship between these factors.
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